×
Log in
Get Started
Travel
Technology
Sports
Marketing
Education
Career
Social Media
+ Explore all categories
Report -
Neoadjuvante (Primäre) systemische Therapie · endokrin-sensitiver Erkrankung 1a A ++ Komplettierung der Trastuzumab- Behandlung auf bis zu 1 Jahr bei HER2-positiver Erkrankung 2b
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Please pass captcha verification before submit form